Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Major breakthrough in TB diagnosis
DNA
Scientists used genome techonology to isolate different strains of TB.
Scientists use genome sequencing to isolate strains of TB

Researchers in the UK have made a world-first breakthrough in the diagnosis of tuberculosis (TB).

According to BBC News, scientists at the Universities of Oxford and Birmingham have managed to isolate different strains of the disease using genome sequencing.

This means that patients will receive a diagnosis much faster, instead of waiting months for treatment.

Health secretary Jeremy Hunt said that the breakthrough "will save lives".

While incidents of TB in the UK have fallen in recent years, there are still some 6,000 cases reported each year. 

The illness is associated with health inequality, affecting people in deprived communities seven times more than people in the least deprived areas.

Scientists say they can identify the DNA strains in different samples in less than a week. As well as allowing patients to begin recovery sooner, this will also reduce the chance of infection spreading.

“We’re able to provide information on the species of organism and the drugs to which it may be resistant if it’s TB,” explained consultant microbiologist Dr Grace Smith.

This is the first time anyone in the world has applied genome technology on such a large scale, according to Public Health England.

The announcement comes as a new study shows that efforts to control the disease could be severely hampered by the rise in drug-resistant bacteria.

Published in The Lancet, the study found that one in five global cases of the disease is now resistant to at least one major treatment drug.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.